Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis
Authors
Keywords
Exosome, cisplatin resistance, NSCLC, FSP1, ferroptosis, m6A modification
Journal
LIFE SCIENCES
Volume 276, Issue -, Pages 119399
Publisher
Elsevier BV
Online
2021-03-27
DOI
10.1016/j.lfs.2021.119399
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG
- (2020) Omprakash Shriwas et al. APOPTOSIS
- miR-600 inhibits lung cancer via downregulating the expression of METTL3
- (2019) Wenwen Wei et al. Cancer Management and Research
- The Induction of Ferroptosis by Impairing STAT3/Nrf2/GPx4 Signaling Enhances the Sensitivity of Osteosarcoma Cells to Cisplatin
- (2019) Qiang Liu et al. CELL BIOLOGY INTERNATIONAL
- Downregulation of miR-4443 and miR-5195-3p in ovarian cancer tissue contributes to metastasis and tumorigenesis
- (2019) Seyed Omar Ebrahimi et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3/GSDME activation
- (2019) Cheng-cheng Zhang et al. APOPTOSIS
- Reassessment of Exosome Composition
- (2019) Dennis K. Jeppesen et al. CELL
- Zfp217 mediates m6A mRNA methylation to orchestrate transcriptional and post-transcriptional regulation to promote adipogenic differentiation
- (2019) Tongxing Song et al. NUCLEIC ACIDS RESEARCH
- Efficacy and Safety of First-Line Carboplatin- versus Cisplatin-based Chemotherapy for Non-Small Cell Lung Cancer: A Meta-Analysis
- (2019) Frank Griesinger et al. LUNG CANCER
- N6-methyladenosine RNA modification–mediated cellular metabolism rewiring inhibits viral replication
- (2019) Yang Liu et al. SCIENCE
- Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy
- (2019) Yuzhu Ma et al. International Journal of Nanomedicine
- FSP1 is a glutathione-independent ferroptosis suppressor
- (2019) Sebastian Doll et al. NATURE
- Dissecting the m6A methylation affection on afatinib resistance in non-small cell lung cancer
- (2019) Qianqian Meng et al. PHARMACOGENOMICS JOURNAL
- Multiple Functions and Mechanisms Underlying the Role of METTL3 in Human Cancers
- (2019) Wenhui Zheng et al. Frontiers in Oncology
- BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC
- (2018) Lauren MacDonagh et al. CANCER LETTERS
- Novel insights on m6A RNA methylation in tumorigenesis: a double-edged sword
- (2018) Shaoyun Wang et al. Molecular Cancer
- LncRNA MNX1-AS1 promotes glioblastoma progression through inhibition of miR-4443
- (2018) Yan Gao et al. ONCOLOGY RESEARCH
- N6-methyladenosine links RNA metabolism to cancer progression
- (2018) Dongjun Dai et al. Cell Death & Disease
- Ferroptosis: A Novel Anti-tumor Action for Cisplatin
- (2018) Jipeng Guo et al. Cancer Research and Treatment
- The roles of tumor-derived exosomes in non-small cell lung cancer and their clinical implications
- (2018) Hongmei Zheng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A dynamic N6-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors
- (2018) Fei Yan et al. CELL RESEARCH
- Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells
- (2017) Peiming Zheng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p
- (2017) Feng Wei et al. Molecular Cancer
- Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control
- (2017) Isaia Barbieri et al. NATURE
- Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer
- (2017) Lu Xiao et al. Cell Death & Disease
- Comparative analysis of microRNA expression profiles between A549, A549/DDP and their respective exosomes
- (2017) Xiaobing Qin et al. Oncotarget
- Leptin and insulin up-regulate miR-4443 to suppress NCOA1 and TRAF4, and decrease the invasiveness of human colon cancer cells
- (2016) Ari Meerson et al. BMC CANCER
- Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA
- (2016) Chuanzhao Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy
- (2015) Kishore B. Challagundla et al. JNCI-Journal of the National Cancer Institute
- Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy
- (2015) Kishore B. Challagundla et al. JNCI-Journal of the National Cancer Institute
- Suppression of basal autophagy reduces lung cancer cell proliferation and enhances caspase-dependent and -independent apoptosis by stimulating ROS formation
- (2012) Vitaliy O. Kaminskyy et al. Autophagy
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway
- (2012) Guanglei Zhuang et al. EMBO JOURNAL
- Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non-Small Cell Lung Cancer
- (2010) P. Ceppi et al. MOLECULAR CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started